Table 2.
Biological functions identified by GO term enrichment as uniquely affected by RDX in different treatments.
| Liver 24 hr after exposure | EASE score | 24 hr exposure of primary hepatocyte cells | EASE score | 48 hr exposure of primary hepatocyte cells | EASE score |
| metabolism | 9.00E-04 | pathogenesis | 2.30E-03 | physiological process | 3.75E-02 |
| lipid metabolism | 9.00E-04 | lipid transport | 1.78E-02 | perception of abiotic stimulus | 4.14E-02 |
| fatty acid metabolism | 5.50E-03 | amino acid metabolism | 2.77E-02 | protein metabolism | 4.27E-02 |
| carboxylic acid metabolism | 5.60E-03 | energy derivation by oxidation of organic compounds | 3.22E-02 | ||
| glutathione conjugation reaction | 7.00E-03 | cholesterol metabolism | 3.33E-02 | ||
| ubiquitin-dependent protein catabolism | 1.32E-02 | amino acid and derivative metabolism | 3.36E-02 | ||
| lipid biosynthesis | 1.88E-02 | RNA processing | 3.90E-02 | ||
| sodium ion transport | 3.47E-02 | ||||
| blood pressure | 4.00E-02 |
Data sets were comprised of significantly changed genes as identified by ANOVA in all doses within a tissue or cell exposure time. An enrichment of terms was considered significant when EASE scores were less than 0.05 and a within system false discovery rate was less than 0.125.